<DOC>
	<DOCNO>NCT01429467</DOCNO>
	<brief_summary>The aim study see glycaemic control glycaemic variability affect level HIF , VEGF , erythropoietin cortisol Paediatric Type 1 diabetic insulin pump therapy .</brief_summary>
	<brief_title>Glucose Variability Type 1 Diabetes Its Effect Factors That Influence New Vessel Formation</brief_title>
	<detailed_description>The study two part . The first phase look current paediatric type 1 diabetic Tayside continuous subcutaneous insulin pump therapy measure level Hypoxia-Inducible Factor ( HIF ) , Vascular Endothelial Growth Factor ( VEGF ) , erythropoietin cortisol . This help answer question ; Does glucose control ( express HbA1c ) effect level HIF , VEGF , erythropoietin cortisol ? To knowledge first human study compare HIF , VEGF , erythropoietin cortisol affect glucose control The second phase trial choose 10 patient insulin pump therapy use continuous glucose monitor ( CGM ) , monitor glucose variability period 6 week . After period level HIF , VEGF , erythropoietin cortisol measure . This help answer question whether relationship glucose variability level HIF , VEGF , erythropoietin cortisol . As know factor stimulate episode hypo hyperglycaemia , hypothesise factor low participant demonstrate reduce glucose variability . It first study give detailed information relationship HIF , VEGF , erythropoietin cortisol glucose variability . By use telemedicine session week 1 , 3 5 participant wear CGM aim improve participant 's glucose variability . This help give information glucose variability factor well give evidence use telemedicine CGM improve glycaemic control adolescent diabetic .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Phase 1 inclusion : Patients Type 1 Diabetes On insulin pump therapy . Aged 5 year 18 year . Phase 2 inclusion : Patents Type 1 Diabetes Diabetes diagnosis 1 year On insulin pump therapy minimum six month Access computer internet access telephone Agree wear CGM 6 week Aged 12 year 18 year Patients pump therapy Patient le 5 year great 18 year Phase 2 patient pump therapy le 6 month Phase 2 patient without access internet telephone . Phase 2 patient less 12 year great 18 year Patients good understanding English</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Glucose Variability</keyword>
	<keyword>Continuous Glucose Monitoring</keyword>
	<keyword>Hypoxia-inducible Factor ( HIF )</keyword>
	<keyword>Vascular Endothelial Growth Factor ( VEGF )</keyword>
	<keyword>Erythropoietin</keyword>
	<keyword>Cortisol</keyword>
</DOC>